Therapeutic Cancer Vaccination Targeting Shared Tumor Associated Antigens in Combination with Azacitidine for High Risk Myelodysplastic Syndrome - a Phase I Clinical Trial

Staffan Holmberg-Thyden; Inge Hogh Dufva; Anne Ortved Gang; Marie Fredslund Breinholt; Lone Schejbel; Mette Klarskov Andersen; Mohammad Kadivar; Inge Marie Svane; Kirsten Gronbaek; Sine Reker Hadrup; Daniel El Fassi

doi:10.1182/blood-2020-142806

Therapeutic Cancer Vaccination Targeting Shared Tumor Associated Antigens in Combination with Azacitidine for High Risk Myelodysplastic Syndrome - a Phase I Clinical Trial

Staffan Holmberg-Thyden, Inge Hogh Dufva, Anne Ortved Gang, Marie Fredslund Breinholt, Lone Schejbel, Mette Klarskov Andersen, Mohammad Kadivar, Inge Marie Svane, Kirsten Gronbaek, Sine Reker Hadrup, Daniel El Fassi

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Original language	English
Journal	Blood
Volume	136
Issue number	Supplement 1
Pages (from-to)	23-24
ISSN	0006-4971
DOIs	https://doi.org/10.1182/blood-2020-142806
Publication status	Published - 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1182/blood-2020-142806

OpenUrl availability

Full text

Cite this

Holmberg-Thyden, S., Dufva, I. H., Gang, A. O., Breinholt, M. F., Schejbel, L., Andersen, M. K., Kadivar, M., Svane, I. M., Gronbaek, K., Hadrup, S. R., & El Fassi, D. (2020). Therapeutic Cancer Vaccination Targeting Shared Tumor Associated Antigens in Combination with Azacitidine for High Risk Myelodysplastic Syndrome - a Phase I Clinical Trial. Blood, 136(Supplement 1), 23-24. https://doi.org/10.1182/blood-2020-142806

@article{337a8b0e99704717be6b1c89680f4b6c,

title = "Therapeutic Cancer Vaccination Targeting Shared Tumor Associated Antigens in Combination with Azacitidine for High Risk Myelodysplastic Syndrome - a Phase I Clinical Trial",

author = "Staffan Holmberg-Thyden and Dufva, {Inge Hogh} and Gang, {Anne Ortved} and Breinholt, {Marie Fredslund} and Lone Schejbel and Andersen, {Mette Klarskov} and Mohammad Kadivar and Svane, {Inge Marie} and Kirsten Gronbaek and Hadrup, {Sine Reker} and {El Fassi}, Daniel",

year = "2020",

doi = "10.1182/blood-2020-142806",

language = "English",

volume = "136",

pages = "23--24",

journal = "Blood",

issn = "0006-4971",

publisher = "Elsevier",

number = "Supplement 1",

}

Holmberg-Thyden, S, Dufva, IH, Gang, AO, Breinholt, MF, Schejbel, L, Andersen, MK, Kadivar, M, Svane, IM, Gronbaek, K, Hadrup, SR & El Fassi, D 2020, 'Therapeutic Cancer Vaccination Targeting Shared Tumor Associated Antigens in Combination with Azacitidine for High Risk Myelodysplastic Syndrome - a Phase I Clinical Trial', Blood, vol. 136, no. Supplement 1, pp. 23-24. https://doi.org/10.1182/blood-2020-142806

Therapeutic Cancer Vaccination Targeting Shared Tumor Associated Antigens in Combination with Azacitidine for High Risk Myelodysplastic Syndrome - a Phase I Clinical Trial. / Holmberg-Thyden, Staffan; Dufva, Inge Hogh; Gang, Anne Ortved et al.
In: Blood, Vol. 136, No. Supplement 1, 2020, p. 23-24.

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

TY - ABST

T1 - Therapeutic Cancer Vaccination Targeting Shared Tumor Associated Antigens in Combination with Azacitidine for High Risk Myelodysplastic Syndrome - a Phase I Clinical Trial

AU - Holmberg-Thyden, Staffan

AU - Dufva, Inge Hogh

AU - Gang, Anne Ortved

AU - Breinholt, Marie Fredslund

AU - Schejbel, Lone

AU - Andersen, Mette Klarskov

AU - Kadivar, Mohammad

AU - Svane, Inge Marie

AU - Gronbaek, Kirsten

AU - Hadrup, Sine Reker

AU - El Fassi, Daniel

PY - 2020

Y1 - 2020

U2 - 10.1182/blood-2020-142806

DO - 10.1182/blood-2020-142806

M3 - Conference abstract in journal

SN - 0006-4971

VL - 136

SP - 23

EP - 24

JO - Blood

JF - Blood

IS - Supplement 1

ER -